Search Results - "O’Connor, Jason B."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age

    Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age by Ly, Trang T., Layne, Jennifer E., Huyett, Lauren M., Nazzaro, David, O’Connor, Jason B.

    Published in Journal of diabetes science and technology (01-01-2019)
    “…The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia

    978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia by FORLENZA, GREGORY P., BUCKINGHAM, BRUCE A., SHERR, JENNIFER, WADWA, R. PAUL, GALDERISI, ALFONSO, EKHLASPOUR, LAYA, BERGET, CARI, HSU, LIANA, ZGORSKI, MELINDA, LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, VIENNEAU, TODD, HUYETT, LAUREN M., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Customization of glucose targets in hybrid closed-loop (HCL) systems is important to enable tailored glucose management and safe onboarding across a wide range…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes

    215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes by BUCKINGHAM, BRUCE A., FORLENZA, GREGORY P., SHERR, JENNIFER, GALDERISI, ALFONSO, EKHLASPOUR, LAYA, LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, HUYETT, LAUREN M., LAYNE, JENNIFER E., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…T1D therapies must be proven safe for young children, who face unique diabetes management challenges. The safety and performance of the Omnipod® hybrid…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia

    1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia by SHERR, JENNIFER, BUCKINGHAM, BRUCE A., FORLENZA, GREGORY P., GALDERISI, ALFONSO, EKHLASPOUR, LAYA, WADWA, R. PAUL, ZGORSKI, MELINDA, KINGMAN, RYAN S., BERGET, CARI, LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, VIENNEAU, TODD, HUYETT, LAUREN M., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Customization of glucose targets in hybrid closed-loop (HCL) systems is important to enable tailored glucose management and safe onboarding across a wide range…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions

    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions by SHERR, JENNIFER, FORLENZA, GREGORY P., BUCKINGHAM, BRUCE, PEYSER, THOMAS A., LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, HUYETT, LAUREN M., LAYNE, JENNIFER E., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…The safety and performance of the Omnipod® hybrid closed-loop (HCL) personalized model predictive control algorithm was assessed in children with type 1…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adults with Type 1 Diabetes over Five Days Under Free-Living Conditions

    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adults with Type 1 Diabetes over Five Days Under Free-Living Conditions by BUCKINGHAM, BRUCE A., SHERR, JENNIFER, FORLENZA, GREGORY P., PEYSER, THOMAS A., LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, HUYETT, LAUREN M., LAYNE, JENNIFER E., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…The safety and performance of the Omnipod® hybrid closed-loop (HCL) personalized model predictive control algorithm was assessed in adults with type 1 diabetes…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adolescents with Type 1 Diabetes over Five Days Under Free-Living Conditions

    Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adolescents with Type 1 Diabetes over Five Days Under Free-Living Conditions by FORLENZA, GREGORY P., BUCKINGHAM, BRUCE, SHERR, JENNIFER, PEYSER, THOMAS A., LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, HUYETT, LAUREN M., LAYNE, JENNIFER E., LY, TRANG T.

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…The safety and performance of the Omnipod® hybrid closed-loop (HCL) personalized model predictive control algorithm was assessed in adolescents with type 1…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: